Sponsor

Biotheus Inc.

Clinical research sponsor

Published trials5

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

5 shown

PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung CancerNCT06616532 · lead sponsor · 2024-11-13

ACTIVE_NOT_RECRUITING

PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBCNCT06419621 · lead sponsor · 2024-06-11

ACTIVE_NOT_RECRUITING

A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLCNCT05844150 · lead sponsor · 2023-06-01

ACTIVE_NOT_RECRUITING

A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBCNCT05918133 · lead sponsor · 2022-07-01

ACTIVE_NOT_RECRUITING

A Study of PM8002 in Combination With Chemotherapy in Patients With SCLCNCT05879068 · lead sponsor · 2022-05-27

ACTIVE_NOT_RECRUITING

Sponsor roles

lead sponsor5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.